Europe
4TEEN4 Pharmaceuticals GmbH announced the closing of a EUR 6.9 million Series A financing round.
Inceptua announced that Paul Wituschek has been appointed President North America.
MC Services AG, a leading international public relations and investor relations firm, announced today that it will be, for the first time, a media partner for Biotech ShowcaseTM.
Use of innovative technology in the treatment of brain tumor patients, now also in Zwickau, the central treatment center in East Germany.
Scientists have found that faults in the blood-brain barrier lead to increased immune activity in the brain of mice. The researchers published the findings in two scientific papers in Science Translational Medicine.
Changes in heart rate, due to low oxygen conditions, experienced by the fetus during pregnancy, could be used to predict the future heart health of babies, shows research published in The Journal of Physiology.
Pharma and biotech companies strengthen their leadership teams and boards with this week’s hires.
“This extraordinary pivotal data confirms voclosporin’s ability to achieve statistically significant improvements in clinically meaningful endpoints for this complex disease, with a comparable safety profile to the current standard of care,” said Neil Solomons, Aurinia’s chief medical officer.
Phoenix Solutions AS, a clinical-stage biotech company, announced the appointment of Dr. Jean-Michel Cosséry to its Board of Directors.
Bpifrance and Pfizer Ventures co-led international investor syndicate
PRESS RELEASES